Shilpa Medicare Analytical Services Division gets 2 minor observations from USFDA
Karnataka: Shilpa Medicare has announced that the US Food and Drug Administration (USFDA) has closed the inspection with two minor observations at the company's Analytical Services Division situated at Unit 7, Nacharam, Hyderabad, Telangana. This is a full GMP inspection.The unit has been inspected by US FDA from 08 March 2023 to 10 March 2023."The Company will be submitting the responses to...
Karnataka: Shilpa Medicare has announced that the US Food and Drug Administration (USFDA) has closed the inspection with two minor observations at the company's Analytical Services Division situated at Unit 7, Nacharam, Hyderabad, Telangana. This is a full GMP inspection.
The unit has been inspected by US FDA from 08 March 2023 to 10 March 2023.
"The inspection is closed with 2 minor observations, which are related to improvements in existing procedures and are addressable," the company added.
Read also: Shilpa Medicare Hyderabad division gets USFDA clearance
Shilpa Medicare Limited started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML was started in November 1989. Today Shilpa Medicare Limited is a global brand in manufacturing and supplying of affordable API and Formulation globally in different regulated markets.
Read also: Shilpa Medicare Bengaluru facility gets registered with Ministry of Health, UAE
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd